What is a significant benefit of the ultra low BurstDR settings found in the BOLDER study?

The ultra low BurstDR settings in the BOLDER study offer a significant benefit by maximizing therapeutic longevity. This means that patients can experience sustained relief from symptoms over a longer period, which is crucial in managing chronic conditions. By optimizing the parameters used in BurstDR therapy, clinicians can achieve effective pain control while minimizing the frequency of interventions required, thereby potentially improving the overall quality of life for patients.

Maximized therapeutic longevity indicates that patients may not only have a reduction in symptoms but can also expect that this relief will be durable, allowing them to engage more fully in daily activities without the constant concern of their pain resurfacing. This contrasts with options that suggest negative outcomes, as the focus of BurstDR technology is to enhance treatment effectiveness and patient well-being.